Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Manion Douglas J. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 4 Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,437 shares @ $9.81, valued at $43.5k
Exercised 15,575 restricted stock units @ $0
03/17/2023 4 Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Bought 6,300 shares @ $7.8623, valued at $49.5k
03/09/2023 4 Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Bought 6,500 shares @ $7.735, valued at $50.3k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2022 4 Manion Douglas J. (Pres and COO) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 217,800 options to buy @ $13.62, valued at $3M
Granted 62,300 restricted stock units @ $0
08/02/2022 3 Manion Douglas J. (Pres and COO) has filed a Form 3 on Aclaris Therapeutics, Inc.
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Manion Douglas J. (EVP Research & Development) has filed a Form 4 on ARENA PHARMACEUTICALS INC
Txns: Granted 21,462 shares @ $0
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy